Literature DB >> 32984514

HYPERPROLACTINEMIA IN A TRANSGENDER MALE.

Sapna Patel, Jessica Abramowitz.   

Abstract

OBJECTIVE: We present a case of hyperprolactinemia in a transgender male. We discuss the various etiologies for hyperprolactinemia in this population of patients and discuss management options.
METHODS: We present a case report and review of the literature. A 29-year-old transgender male treated with gender-affirming hormone therapy with testosterone presented with hyperprolactinemia.
RESULTS: Labs revealed an elevated prolactin level. The patient completed further laboratory evaluation as well as imaging with a pituitary magnetic resonance imaging which all revealed normal results. He was wearing a tightly fitted breast binder while awaiting bilateral mastectomy. After bilateral mastectomy prolactin normalized, suggesting breast binding as the cause of the elevated prolactin.
CONCLUSION: This is the only case in the literature which highlights breast binding as a possible cause of an elevated prolactin level. Our case report illustrates the various etiologies associated with an elevated prolactin level and highlights the importance of considering unique etiologies in populations such as transgender males.
Copyright © 2020 AACE.

Entities:  

Year:  2020        PMID: 32984514      PMCID: PMC7279772          DOI: 10.4158/ACCR-2019-0272

Source DB:  PubMed          Journal:  AACE Clin Case Rep        ISSN: 2376-0605


  16 in total

Review 1.  Hyperprolactinemia: pathophysiology and therapeutic approach.

Authors:  Anna Capozzi; Giovanni Scambia; Alfredo Pontecorvi; Stefano Lello
Journal:  Gynecol Endocrinol       Date:  2015-07-06       Impact factor: 2.260

2.  Prolactin release during nursing and breast stimulation in postpartum and nonpostpartum subjects.

Authors:  G L Noel; H K Suh; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1974-03       Impact factor: 5.958

3.  Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.

Authors:  Wylie C Hembree; Peggy T Cohen-Kettenis; Louis Gooren; Sabine E Hannema; Walter J Meyer; M Hassan Murad; Stephen M Rosenthal; Joshua D Safer; Vin Tangpricha; Guy G T'Sjoen
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

4.  The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment.

Authors:  Nienke M Nota; Chantal M Wiepjes; Christel J M de Blok; Louis J G Gooren; Saskia M Peerdeman; Baudewijntje P C Kreukels; Martin den Heijer
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

5.  Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1year study.

Authors:  Benedicto Crespo-Facorro; Victor Ortiz-Garcia de la Foz; Paula Suarez-Pinilla; Elsa M Valdizan; Rocío Pérez-Iglesias; Jose Antonio Amado-Señaris; M Teresa Garcia-Unzueta; Javier Labad; Christopher Correll; Rosa Ayesa-Arriola
Journal:  Schizophr Res       Date:  2017-02-20       Impact factor: 4.939

6.  Transient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate Treatment.

Authors:  Justine Defreyne; Nienke Nota; Cecilia Pereira; Thomas Schreiner; Alessandra D Fisher; Martin den Heijer; Guy T'Sjoen
Journal:  LGBT Health       Date:  2017-09-07       Impact factor: 4.151

7.  Galactorrhea and hyperprolactinemia associated with chest wall injury.

Authors:  J E Morley; M Dawson; H Hodgkinson; W J Kalk
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

8.  Galactorrhoea following surgical procedures to the chest wall: the role of prolactin.

Authors:  I A MacFarlane; M D Rosin
Journal:  Postgrad Med J       Date:  1980-01       Impact factor: 2.401

Review 9.  Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review.

Authors:  H Asscheman; G T'Sjoen; A Lemaire; M Mas; M C Meriggiola; A Mueller; A Kuhn; C Dhejne; N Morel-Journel; L J Gooren
Journal:  Andrologia       Date:  2013-08-15       Impact factor: 2.775

10.  Hyperprolactinemia with Galactorrhea Due to Subclinical Hypothyroidism: A Case Report and Review of Literature.

Authors:  Kashif Aziz; Amir Shahbaz; Muhammad Umair; Mohaddeseh Sharifzadeh; Issac Sachmechi
Journal:  Cureus       Date:  2018-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.